sifrol er 0.375 mg
boehringer ingelheim israel ltd. - pramipexole dihydrochloride monohydrate - tablets extended release - pramipexole dihydrochloride monohydrate 0.375 mg - pramipexole - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.
sifrol er 0.75 mg
boehringer ingelheim israel ltd. - pramipexole dihydrochloride monohydrate - tablets extended release - pramipexole dihydrochloride monohydrate 0.75 mg - pramipexole - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.
sifrol er 1.5 mg
boehringer ingelheim israel ltd. - pramipexole dihydrochloride monohydrate - tablets extended release - pramipexole dihydrochloride monohydrate 1.5 mg - pramipexole - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.
pramipexole aurobindo 0.088 milligram tablets
milpharm limited - pramipexole dihydrochloride monohydrate - tablets - 0.088 milligram - dopamine agonists
pramipexole aurobindo 1.1 milligram tablets
milpharm limited - pramipexole dihydrochloride monohydrate - tablets - 1.1 milligram - dopamine agonists
pramipexole aurobindo 0.18 milligram tablets
milpharm limited - pramipexole dihydrochloride monohydrate - tablets - 0.18 milligram - dopamine agonists
pramipexole aurobindo 0.7 milligram tablets
milpharm limited - pramipexole dihydrochloride monohydrate - tablets - 0.7 milligram - dopamine agonists
prapexin 0.088 milligram tablets
rowex ltd - pramipexole - tablets - 0.088 milligram - dopamine agonists
prapexin 0.18 milligram tablets
rowex ltd - pramipexole - tablets - 0.18 milligram - dopamine agonists
prapexin 0.7 milligram tablets
rowex ltd - pramipexole - tablets - 0.7 milligram - dopamine agonists